Chloroquine exerts neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death

Cui,Chang‑Meng; Gao,Jun‑Ling; Cui,Ying; Sun,Li‑Qian; Wang,Yong‑Chao; Wang,Kai‑Jie; Li,Ran; Tian,Yan‑Xia; Cui,Jian‑Zhong

doi:10.3892/mmr.2015.3611

Chloroquine exerts neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death

Authors:
- Chang‑Meng Cui
- Jun‑Ling Gao
- Ying Cui
- Li‑Qian Sun
- Yong‑Chao Wang
- Kai‑Jie Wang
- Ran Li
- Yan‑Xia Tian
- Jian‑Zhong Cui
View Affiliations

Affiliations: Department of Surgery, Hebei Medical University, Shijiazhung, Hebei 050017, P.R. China, School of Basic Medical Science, Hebei United University, Tangshan, Hebei 063000, P.R. China, Department of Neurosurgery, Tangshan Workers' Hospital, Tangshan, Hebei 063000, P.R. China
Published online on: April 15, 2015 https://doi.org/10.3892/mmr.2015.3611
Pages: 2323-2328

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The antimalarial drug, chloroquine (CQ), has been reported as an autophagy inhibitor in a variety of disorders, including Alzheimer's disease and brain ischemia. To the best of our knowledge, no studies to date have examined the potential for CQ to provide neuroprotection in animal models of traumatic brain injury (TBI). The aim of this study was to investigate the neuroprotective actions of CQ in TBI and to determine the mechanisms underlying this effect. Rats were immediately subjected to a diffuse cortical impact injury caused by a modified weight‑drop device and divided randomly into three groups: sham‑operated, CQ treatment and vehicle. The CQ treatment group was administered CQ (intraperitoneally, 3 mg/kg body weight) immediately following the induction of injury. The co‑localization of neuron‑specific nuclear protein (NeuN) and microtubule‑associated protein 1 light chain 3 (LC3), was followed by immunofluorescent staining. The expression of LC3 and inflammatory cytokines was identified by western blot analysis. Wet‑dry weight method was utilized to evaluate TBI‑induced brain edema. Motor function was evaluated using the Neurological Severity Score (NSS) scale and the Morris water maze was employed to assess spatial learning ability. This study demonstrated that the administration of CQ attenuates TBI‑induced cerebral edema, and the associated motor and cognitive functional deficits that occur post‑injury. Following the induction of cerebral trauma, CQ treatment significantly suppressed neuronal autophagy and reduced expression levels of the inflammatory cytokines, interleukin‑1β (IL‑1β) and tumor necrosis factor‑α (TNF‑α), in the rat hippocampus. Our results have provided in vivo evidence that CQ may exert neuroprotective effects following TBI, in attenuating brain edema and improving neurological functioning, by reducing the damaging consequences of neuronal autophagy and cerebral inflammation.

View Figures

View References

1	Thurman DJ, Alverson C, Dunn KA, Guerrero J and Sniezek JE: Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 14:602–615. 1999. View Article : Google Scholar
2	Davis AE: Mechanisms of traumatic brain injury: biomechanical, structural and cellular considerations. Crit Care Nurs Q. 23:1–13. 2000. View Article : Google Scholar
3	Wang YQ, Wang L, Zhang MY, et al: Necrostatin-1 suppresses autophagy and apoptosis in mice traumatic brain injury model. Neurochem Res. 37:1849–1858. 2012. View Article : Google Scholar : PubMed/NCBI
4	Luo CL, Chen XP, Yang R, et al: Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway. J Neurosci Res. 88:2847–2858. 2010.PubMed/NCBI
5	Shintani T and Klionsky DJ: Autophagy in health and disease: a double-edged sword. Science. 306:990–995. 2004. View Article : Google Scholar : PubMed/NCBI
6	Mizushima N: Autophagy: process and function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar : PubMed/NCBI
7	Galluzzi L, Aaronson SA, Abrams J, et al: Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 16:1093–1107. 2009. View Article : Google Scholar : PubMed/NCBI
8	Lai Y, Hickey RW, Yaming Chen Y, et al: Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J Cereb Blood Flow Metab. 28:540–550. 2008. View Article : Google Scholar
9	Puyal J, Vaslin A, Mottier V and Clarke PG: Postischemic treatment of neonatal cerebral ischemia should target autophagy. Ann Neurol. 66:378–389. 2009. View Article : Google Scholar : PubMed/NCBI
10	Caro LH, Plomp PJ, Wolvetang EJ, Kerkhof C and Meijer AJ: 3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism. Eur J Biochem. 175:325–329. 1988. View Article : Google Scholar : PubMed/NCBI
11	Homewood CA, Warhurst DC, Peters W and Baggaley VC: Lysosomes, pH and the anti-malarial action of chloroquine. Nature. 235:50–52. 1972. View Article : Google Scholar : PubMed/NCBI
12	Slater AF: Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol Ther. 57:203–235. 1993. View Article : Google Scholar : PubMed/NCBI
13	Janku F, McConkey DJ, Hong DS and Kurzrock R: Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol. 8:528–539. 2011. View Article : Google Scholar : PubMed/NCBI
14	Lopez G, Torres K and Lev D: Autophagy blockade enhances HDAC inhibitors’ pro-apoptotic effects: potential implications for the treatment of a therapeutic-resistant malignancy. Autophagy. 7:440–441. 2011. View Article : Google Scholar : PubMed/NCBI
15	Sotelo J, Briceño E and López-González MA: Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 144:337–343. 2006. View Article : Google Scholar : PubMed/NCBI
16	Kimura T, Takabatake Y, Takahashi A and Isaka Y: Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res. 73:3–7. 2013. View Article : Google Scholar : PubMed/NCBI
17	Liu C, Gao Y, Barrett J and Hu B: Autophagy and protein aggregation after brain ischemia. J Neurochem. 115:68–78. 2010. View Article : Google Scholar : PubMed/NCBI
18	Zhang JY, Peng C, Shi H, Wang S, Wang Q and Wang JZ: Inhibition of autophagy causes tau proteolysis by activating calpain in rat brain. J Alzheimers Dis. 16:39–47. 2009.PubMed/NCBI
19	Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H and Demetriadou K: A new model of diffuse brain injury in rats. J Neurosurg. 80:291–300. 1994. View Article : Google Scholar : PubMed/NCBI
20	Tang J, Liu J, Zhou C, et al: Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J Cereb Blood Flow Metab. 24:1133–1145. 2004. View Article : Google Scholar : PubMed/NCBI
21	Beni-Adani L, Gozes I, Cohen Y, et al: A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J Pharmacol Exp Ther. 296:57–63. 2001.
22	Hui-guo L, Kui L, Yan-ning Z and Yong-jian X: Apocynin attenuate spatial learning deficits and oxidative responses to intermittent hypoxia. Sleep Med. 11:205–212. 2010. View Article : Google Scholar : PubMed/NCBI
23	Yi JH and Hazell AS: Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem Int. 48:394–403. 2006. View Article : Google Scholar : PubMed/NCBI
24	Tyurin VA, Tyurina YY, Borisenko GG, et al: Oxidative stress following traumatic brain injury in rats. J Neurochem. 75:2178–2189. 2000. View Article : Google Scholar : PubMed/NCBI
25	Frugier T, Morganti-Kossmann MC, O’Reilly D and McLean CA: In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma. 27:497–507. 2010. View Article : Google Scholar
26	Raghupathi R: Cell death mechanisms following traumatic brain injury. Brain Pathol. 14:215–222. 2004. View Article : Google Scholar : PubMed/NCBI
27	O’Connor WT, Smyth A and Gilchrist MD: Animal models of traumatic brain injury: a critical evaluation. Pharmacol Ther. 130:106–113. 2011. View Article : Google Scholar
28	Diskin T, Tal-Or P, Erlich S, et al: Closed head injury induces upregulation of Beclin 1 at the cortical site of injury. J Neurotrauma. 22:750–762. 2005. View Article : Google Scholar : PubMed/NCBI
29	Erlich S, Alexandrovich A, Shohami E and Pinkas-Kramarski R: Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis. 26:86–93. 2007. View Article : Google Scholar : PubMed/NCBI
30	van den Borne BE, Dijkmans BA, de Rooij H, le Cessie S and Verweij CL: Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol. 24:55–60. 1997.PubMed/NCBI
31	Jang CH, Choi JH, Byun MS and Jue DM: Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysac-charide-stimulated human monocytes/macrophages by different modes. Rheumatology (Oxford). 45:703–710. 2006. View Article : Google Scholar
32	Fullerton HJ, Ditelberg JS, Chen SF, et al: Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol. 44:357–364. 1998. View Article : Google Scholar : PubMed/NCBI
33	Sehgal S, Baker H and Vézina C: Rapamycin (AY-22,989), a new antifungal antibiotic. II Fermentation, isolation and characterization. J Antibiot (Tokyo). 28:727–732. 1975. View Article : Google Scholar